ReShape Lifesciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GOLDFISCHER CARL director
 Common Stock 50,000 N/A N/A
Purchase
GOLDFISCHER CARL director
 Common Stock 20,990 N/A N/A
Purchase
BAY CITY CAPITAL LLC 10 percent owner
 Common Stock 21,000 N/A N/A
Purchase
MPM BIOVENTURES III QP LP
Common Stock 625,000 N/A N/A
Purchase
EVNIN LUKE director
 Common Stock 625,000 N/A N/A
Purchase
GADICKE ANSBERT other: Former 10% Owner
 Common Stock 625,000 N/A N/A
Purchase
ABERDARE GP II, L.L.C. other: Former 10% stockholder
 Common Stock 250,000 N/A N/A
Purchase
INTERWEST MANAGEMENT PARTNERS IX, LLC 10 percent owner
 Common Stock 187,500 N/A N/A
Purchase
KOSKINAS ELLEN E director
 Common Stock 187,500 N/A N/A
Purchase
GOLDFISCHER CARL director
 Common Stock 375,000 N/A N/A
Purchase
HARRISON DONALD C director
 Common Stock 90,000 N/A N/A
Purchase
BAY CITY CAPITAL LLC 10 percent owner
 Common Stock 375,000 N/A N/A
Purchase
KLINGENSTEIN PAUL H director
 Common Stock 247,230 N/A N/A
Purchase
KLINGENSTEIN PAUL H director
 Common Stock 250,000 N/A N/A
Purchase
INTERWEST PARTNERS IX, LP 10 percent owner
 Common Stock 187,500 N/A N/A

Showing 250 to 265 of 265 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: